MRNS
Marinus Pharmaceuticals, Inc
MRNS
MRNS
Delisted
MRNS was delisted on the 10th of February, 2025.
73 hedge funds and large institutions have $139M invested in Marinus Pharmaceuticals, Inc in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 16 increasing their positions, 23 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
73
Holders Change
-10
Holders Change %
-12.05%
% of All Funds
1.23%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
16
Increased
16
Reduced
23
Closed
25
Calls
$425K
Puts
$876K
Net Calls
-$451K
Net Calls Change
-$1.7M
Top Buyers
| 1 |
SCM
1
Suvretta Capital Management
New York
|
$17M |
| 2 |
2
Millennium Management
New York
|
$1.86M |
| 3 |
AC
3
Antara Capital
New York
|
$2.26M |
| 4 |
E
4
Ergoteles
New York
|
$945K |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$1.06M |
Top Sellers
| 1 |
1
BlackRock
New York
|
$4.56M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$630K |
| 3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$1.6M |
| 4 |
4
JPMorgan Chase & Co
New York
|
$10K |
| 5 |
5
Northern Trust
Chicago,
Illinois
|
$277K |
